These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8928409)

  • 1. [Diabetic nephropathy and isolated hyporeninemic hypoaldosteronism].
    Hrnciar J
    Vnitr Lek; 1996 Jun; 42(6):394-9. PubMed ID: 8928409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of long-term treatment of arterial hypertension with Ca antagonists on the renin-angiotensin-aldosterone system in diabetics. Hyporeninemic hypoaldosteronism].
    Hrnciar J; Jakubíková K; Hrnciarová M; Kreze A; Chamulová M
    Vnitr Lek; 1995 Oct; 41(10):661-6. PubMed ID: 8578695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hyporeninemic hypoaldosteronism and the differential diagnosis of hyperkalemia].
    Weidmann P
    Schweiz Med Wochenschr; 1982 Dec; 112(49):1764-74. PubMed ID: 6758113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the cause and the treatment of hyporeninemic selected hypoaldosteronism in diabetic nephropathy.
    Fukuchi S
    Jpn J Med; 1991; 30(6):617-8. PubMed ID: 1798229
    [No Abstract]   [Full Text] [Related]  

  • 5. Prerenal azotemia in a diabetic patient with hyporeninemic hypoaldosteronism and autonomic neuropathy.
    Elisaf MS; Tomos PP; Milionis HJ; Siamopoulos KC
    Diabetes Metab; 1999 Sep; 25(4):344-6. PubMed ID: 10566125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient hyporeninemic hypoaldosteronism in acute glomerulonephritis.
    Watanabe T; Nitta K
    Pediatr Nephrol; 2002 Nov; 17(11):959-63. PubMed ID: 12432442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Arterial hypertension in patients on chronic hemodialysis].
    Zogović J; Mladenović Lj
    Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A study on the pathogenesis of hyporeninemia in diabetics].
    Yamaguchi M
    Nihon Naibunpi Gakkai Zasshi; 1994 Aug; 70(6):573-84. PubMed ID: 7958107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Amylin as an additional possible pathogenic factor in NIDDM and the insulin resistance syndrome].
    Hrnciar J
    Vnitr Lek; 1996 Aug; 42(8):557-60. PubMed ID: 8967027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic nephropathy.
    Ritz E
    Saudi J Kidney Dis Transpl; 2006 Dec; 17(4):481-90. PubMed ID: 17186681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
    Horký K
    Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of calcium inhibitors in the treatment of arterial hypertension].
    Hrnciar J; Hrnciarová M; Jakubíková K
    Vnitr Lek; 1997 Feb; 43(2):74-80. PubMed ID: 9245072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of the onset and progression of peripheral neuropathy and hypertension in NIDDM].
    Jarmuzewska EA; Ghidoni A
    Minerva Med; 2000; 91(1-2):1-15. PubMed ID: 10858728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyporeninemic hypoaldosteronism in a patient with cirrhosis and ascites.
    Escarce JJ
    Arch Intern Med; 1986 Dec; 146(12):2407-8. PubMed ID: 3535721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The angiotensin II inhibition escape phenomenon in patients with type 2 diabetes and diabetic nephropathy].
    Shamkhlova MSh; Trubitsyna NP; Katsaia GV; Goncharov NP; Malysheva NM; Il'in AV; Nikankina LV; Koshel' LV; Shestakova MV
    Ter Arkh; 2008; 80(1):49-52. PubMed ID: 18326228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of lupus nephritis with hyporeninemic hypoaldosteronism].
    Wada J; Makino H; Ota Z; Yokoi T; Nagayama K; Asano K; Fukushima M
    Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):817-24. PubMed ID: 1770640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyporeninemic hypoaldosteronism in diabetic patients with chronic renal failure.
    Grande Villoria J; Macias Nunez JF; Miralles JM; De Castro del Pozo S; Tabernero Romo JM
    Am J Nephrol; 1988; 8(2):127-37. PubMed ID: 3394721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diabetes mellitus and its complications in Japan. Studies on the cause and treatment of hyporeninemic selective hypoaldosteronism in diabetic nephropathy].
    Fukuchi S
    Nihon Naika Gakkai Zasshi; 1991 Sep; 80(9):1434-5. PubMed ID: 1684805
    [No Abstract]   [Full Text] [Related]  

  • 20. [Relation between levels of leptin, insulin and cortisol in persons with the 5H (X) syndrome].
    Hrnciar J; Okapcová J; Lepej J; Gábor D
    Vnitr Lek; 1998 Feb; 44(2):68-75. PubMed ID: 9820079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.